Regulatory Compliance and Controlled Substance Logistics

The contract requires secure transportation and documentation of Schedule III controlled substances in full compliance with DEA, DOT, and DLA regulations, ensuring strict chain-of-custody protocols and regulatory adherence throughout the logistics process. All activities must be executed with heightened security measures to prevent diversion, loss, or unauthorized access, with particular emphasis on handling procedures that meet federal standards for controlled substances. The performance location is designated as APO 09227-0000, indicating operations tied to military or government-controlled facilities overseas, necessitating coordination with Department of Defense supply chains and adherence to international transport guidelines. This is a subcontract under NAICS code 484220, focusing on truck transportation of specialized medical goods, with a response deadline of August 3, 2026, and a posting date of July 26, 2026. The contracting entity is the Medical Supply Chain Pharm FSA under the Department of Defense, implicating that the successful offeror must demonstrate proven experience in secure pharmaceutical logistics, regulatory compliance documentation, and the ability to operate within the constraints of federal defense logistics systems. All parties are expected to maintain comprehensive records, enable audit readiness, and ensure seamless integration with DLA supply chain platforms, with no flexibility permitted in meeting statutory requirements for controlled substance handling.